In summary, ITGAV demonstrated significantly elevated expression levels in digestive system cancers, which were closely associated with poor survival outcomes and exhibited good diagnostic value, indicating a significant connection between ITGAV and the malignant progression of the tumors. Here, ITGAV is linked to digestive system cancer.